Knowledge accumulation and industry evolution : the case of pharma-biotech /
Saved in:
| Imprint: | Cambridge, UK ; New York : Cambridge University Press, 2006. |
|---|---|
| Description: | xvii, 446 p. : ill. ; 24 cm. |
| Language: | English |
| Subject: | |
| Format: | Print Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/6228538 |
Table of Contents:
- List of figures
- List of tables
- List of contributors
- Acknowledgments
- 1. Introduction
- Part I. Innovation and industry evolution
- 2. Pharmaceutical innovation as a process of creative destruction
- 3. The evolution of pharmaceutical innovation
- 4. Firm and regional determinants in innovation models: evidence from biotechnology and traditional chemicals
- 5. Innovation and industry evolution: a comment
- Part II. Firm growth and market structure
- 6. Heterogeneity and firm growth in the pharmaceutical industry
- 7. Growth and diversification patterns of the worldwide pharmaceutical industry
- 8. Entry, market structure, and innovation in a "history-friendly" model of the evolution of the pharmaceutical industry
- 9. The growth of pharmaceutical firms: a comment
- Part III. Policy implications
- 10. The effects of research tool patents and licensing on biomedical innovation
- 11. Upstream patents and public health: the case of genetic testing for breast cancer
- 12. Competition, regulation, and intellectual property management in genetically modified foods: evidence from survey data
- 13. Governance, policy, and industry strategies: pharmaceuticals and agro-biotechnology
- 14. The dynamics of knowledge accumulation, regulation, and appropriability in the pharma-biotech sector: policy issues
- Index
